pediatrix-Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates

Company Performance - Pediatrix Medical Group reported quarterly earnings of $0.44 per share, exceeding the Zacks Consensus Estimate of$ 0.37 per share, and up from $0.32 per share a year ago, representing an earnings surprise of 18.92% [1] - The company posted revenues of$ 511.16 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 2.21%, compared to $506.61 million in the same quarter last year [2] - Over the last four quarters, the company has surpassed consensus EPS estimates three times and topped consensus revenue estimates just once [2] Stock Performance - Pediatrix Medical Group shares have increased approximately 32.5% since the beginning of the year, outperforming the S&P 500's gain of 19.6% [3] - The current status of estimate revisions for the company is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the coming quarter is$ 0.37 on revenues of $488.38 million, and for the current fiscal year, it is$ 1.28 on revenues of $1.99 billion [7] - The outlook for the Medical Services industry, where Pediatrix operates, is currently in the bottom 39% of Zacks industries, which may impact the stock's performance [8]